Mon. May 25th, 2026
Spread the love

Welcome to the Dotifi Referral program!

The Dotifi Referral Program allows existing Dotifi Network Creators (Advocates) to refer their fellow Creators (Referrals). It is an opportunity for every user to earn an additional credit bonus that can be used to pay their subscription fee. The bonus varies, depending on the number of networks the Referrer creates in their first 24 hours. Every Network creator who wants to participate in the Dotifi Referral Program automatically agrees to the Terms of Service and Privacy Policy.

How does it work?

Existing Dotifi Network Creators (Advocates) can refer another person (Referral) by sending them a unique referral link generated in the Referral Program section in their Personal Account page. If the Referral registers a network and passes the trial period, the Advocate is eligible to receive a credit bonus of 50% of the Referral’s first monthly payment or 10% of the Referral’s first annual payment.

Details

  • Bonuses are credited only for newly attracted users.
  • If the Referral doesn’t use the Advocate’s invite link to sign up, then the Advocate doesn’t get the bonus for that Referral.
  • Payouts to the Advocates are made on a Net 30 basis. That means the Advocate is paid 30 days after the advocacy takes place.
    Consider this example. Erica referred her schoolmate Josh to join Dotifi. Josh signed up for a 14-day free trial on June 1. For two weeks, he explored the platform’s functionality and took his first steps. On June 15, he subscribed for a Performance Monthly package. June 15 was the date when the advocacy took place. Erica will be paid 30 days after the advocacy date, namely, July 15.
  • Why is the payout model designed this way? It is to prevent fraud or cheating. The Referral may ask for a refund or even make a chargeback.
  • It is important to understand that we are talking about virtual money, which we call credits. These funds are charged to your Dotifi account, but they cannot be withdrawn. However, they can be used inside the platform. Once the Referral signs up for the trial period, you get a chance of obtaiDotifi credits on your personal account. In two weeks, when the trial period ends, the referred user becomes a paid subscriber. Then you automatically become an Advocate. Funds will be charged to your account 30 days after the Referral’s subscription date. Important notice: The bonus will not be given to the Advocate if the Referral makes a chargeback or asks for a refund. Thus, the 30-day window is required to prevent fraud.
  • Only one referral link can be used by an account. If a Referral receives multiple links, then the bonus will be given to the Advocate whose link was used by the Referral to sign up for the free trial.

Dotifi reserves the right to make changes to the Referral Program, referral bonus rates, and the program terms at any time. Dotifi can also terminate this Referral Program or any user’s participation in the program at any time and for any reason. In case you signed up for the Referral Program but no longer want to participate in it, simply deactivate your referral link. To do it, please email us with the subject “Terminate” at referral@Dotifi.com. Make sure you send the email from the address you used to sign up for the program. We will process your application and cancel your participation.

Dotifi Referral Program is an opportunity for every Network Creator to earn credits that can be used inside of the platform.

The process is very straightforward:

  1. You generate a unique referral link and share it with the web.
  2. The user follows the link and signs up at Dotifi for a free trial.
  3. The user becomes a paid subscriber after 14 days. You become an advocate and get a credit.

Talking numbers it is even easier:

  1. You get 50% of the amount of the monthly subscribed user
  2. You get 10% of the amount of the annually subscribed user.

Example: Aaron is a Network Creator at Dotifi. He generates a unique link and shares with Amanda. Amanda follows the link and signs up for a free trial on Jul 1. She learns the platform functionality and happily subscribes at Dotifi for Performance Monthly ($59) package on Jul 15. Aaron gets $29.5 to his Dotifi account on Aug 15. (If Amanda subscribes for Performance Annual ($588) package, Aaron gets $58.8)

Dotifi Referral Program

50% credit per monthly subscriptions.
10% credit per annual subscriptions.

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.